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Abstract
Optimal norepinephrine levels in the prefrontal cortex (PFC) increase delay-related firing and enhance working memory,
whereas stress-related or pathologically high levels of norepinephrine are believed to inhibit working memory via a1
adrenoceptors. However, it has been shown that activation of Gq-coupled and phospholipase C-linked receptors can induce
persistent firing, a cellular correlate of working memory, in cortical pyramidal neurons. Therefore, despite its importance in
stress and cognition, the exact role of norepinephrine in modulating PFC activity remains elusive. Using electrophysiology
and optogenetics, we report here that norepinephrine induces persistent firing in pyramidal neurons of the PFC
independent of recurrent fast synaptic excitation. This persistent excitatory effect involves presynaptic a1 adrenoceptors
facilitating glutamate release and subsequent activation of postsynaptic mGluR5 receptors, and is enhanced by
postsynaptic a2 adrenoceptors inhibiting HCN channel activity. Activation of a2 adrenoceptors or inhibition of HCN
channels also enhances cholinergic persistent responses in pyramidal neurons, providing a mechanism of crosstalk between
noradrenergic and cholinergic inputs. The present study describes a novel cellular basis for the noradrenergic control of
cortical information processing and supports a synergistic combination of intrinsic and network mechanisms for the
expression of mnemonic properties in pyramidal neurons.
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Introduction
The prefrontal cortex (PFC) plays a significant role in high order
brain functions such as working memory [1–3], a process that
refers to the ability to maintain relevant information in a
temporary buffer to guide behaviour. Dysfunction of PFC neural
networks occurs in many psychiatric disorders including attention
deficit hyperactivity disorder and post-traumatic stress disorder
(PTSD) which are associated with hypersensitivity to acute stress
and deficits in working memory. It has long been known that
working memory function is correlated with delay-related persis-
tent neuronal firing and increased fMRI signal in the PFC of
animals and human subjects performing working memory tasks
[4–9]. Persistent firing which outlasts the original stimulus can be
sustained via recurrent network excitation within microcircuits of
layer 2/3 pyramidal neurons of the PFC or from afferent inputs of
subcortical areas [3,10,11]. In vivo and in vitro experiments have
shown that persistent firing can also be observed following a slow
afterdepolarization in the presence of muscarinic or metabotropic
glutamate receptor activation [12–19] Several reports have
confirmed that pyramidal neurons exhibit intrinsic persistent
firing independent of ionotropic synaptic transmission [20–24].
Despite the known impact of stress and imbalanced monoamine
levels on PFC function, the mechanisms underlying the modula-
tion of intrinsic persistent firing by norepinephrine (NE) have not
been addressed.
The PFC receives dense noradrenergic innervation from the
locus coeruleus. Optimal levels of NE released during waking have
been shown to enhance neuronal activity in the PFC and improve
spatial working memory performance in rats and monkeys via the
activation of postsynaptic a2 adrenoceptors [1,25,26]. Activation
of the phospholipase C pathway by postsynaptic metabotropic Gq-
coupled receptors such as muscarinic receptors or mGluR5
induces long-lasting persistent neuronal firing in pyramidal
neurons of the entorhinal cortex [20,24] as well as the PFC
[22,27]. However, recent studies have reported that activation of
postsynaptic Gq-coupled a1 adrenoceptors and PKC inhibits
persistent activity of prefrontal pyramidal neurons and impairs
working memory performance in monkeys [28,29]. Therefore, in
order to clarify the exact role of a1 adrenoceptors and to
understand the mechanism of noradrenergic modulation on
prefrontal functions, the present study investigated the effect of
NE on pyramidal neurons at the single cell level using patch clamp
recording combined with optogenetic activation of noradrenergic
fibers in acute brain slices. We found that both exogenous NE and
endogenous NE released from the locus coeruleus induce
persistent firing in pyramidal neurons of the PFC. We provide
evidence that noradrenergic persistent responses are mainly
mediated by a synergy between presynaptic a1 adrenoceptor-
mediated enhancement of glutamate release and postsynaptic a2
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adrenoceptor-mediated inhibition of hyperpolarization-activated
cyclic nucleotide-gated (HCN) cation channels.
Materials and Methods
Electrophysiological Recording
All experimental procedures were approved by the McGill
University Animal Care Committee and were in compliance with
the guidelines of the Canadian Council on Animal Care. Acute
brain slices were obtained from adult Long-Evans rats (20–23 days
old) (Charles River Canada, Saint-Constant, Quebec, Canada) or
transgenic mice expressing ChR2 (see below) according to a
procedure described previously [22]. Animals were anesthetized
with a ketamine:xylazine cocktail (60:5 mg/kg) and transcardially
perfused with ice-cold choline chloride–based artificial cerebro-
spinal fluid (cutting solution) consisting of (in mM): 110 choline-Cl,
1.25 NaH2PO4, 25 NaHCO3, 7 MgCl2, 0.5 CaCl2, 2.5 KCl, 7
glucose, 3 pyruvic acid, and 1.3 ascorbic acid, bubbled with
carbogen (O2 95%, CO2 5%). Coronal rat or mouse brain slices
(300 mm) were prepared from the forebrain. Briefly, following
transcardial perfusion and decapitation, the rat brain was exposed
dorsally and was cut vertically between the cerebral cortex and
cerebellum. The brain, now devoid of the cerebellum and
brainstem, was quickly removed from the cranial cavity and
immersed in ice-cold cutting solution for 1–2 min. Coronal slices
containing the medial PFC including the rostral anterior cingulate
cortex and prelimbic cortex (Bregma 2.28 , 3.72 mm in rats,
according to Paxinos and Watson 1998; and Bregma 1.10 ,
1.98 mm in mice, Paxinos and Franklin 2001) were obtained using
a vibratome Leica VT1000S (Richmond Hill, Ontario) in the
same solution. Brain slices were transferred to a standard
extracellular solution (see below) to settle down at room
temperature for at least 1 h before recording.
Brain slices were placed in a recording chamber mounted on
the stage of an upright microscope Axioskop (Zeiss, Oberkochen,
Germany) equipped with a 63X water immersion objective and
differential contrast optics. A near-infrared charged-coupled
device camera (Sony XC-75) was used to visualize the neurons.
Brain slices were stabilized using a U-shaped stainless steel anchor
with LycraH threads at 1.5 mm spacing (Warner Instruments,
Hamden, CT). Pyramidal neurons located in layer 2/3 or outer
layer 5 with a typical pyramidal shape were chosen for
electrophysiological recording. Slice perfusion was driven by
gravity at a speed of 0.5–1 ml/min. The temperature of the
perfusion solution was maintained at 32–33uC using a TC-324B
temperature controller (Warner Instruments, Hamden, CT). Patch
pipettes (5–7 MV) were pulled on a Brown Flaming puller (Model
P-97, Sutter Instruments, Novato, CA) using borosilicate glass
electrodes. Tight seals (,5 GV) were obtained by applying
constant negative pressure on the patch pipette. Electrical signals
were amplified using an Axopatch 200B amplifier (Axon
Instruments, Molecular Devices, Sunnyvale, CA), low-pass-filtered
at 5 kHz, digitized at 10 kHz via a Digidata 1322A interface
(Axon Instruments) and stored on a Pentium computer using the
pClamp 9.2.1.8 software (Axon Instruments) for off-line analysis.
In the present study, all cells were quiescent at rest and had a
resting membrane potential ranging from 260 to 280 mV
(median 273 mV). Cells with a resting membrane potential more
positive than –55 mV were discarded. In current clamp record-
ings, the holding current was around 0 pA and slightly adjusted to
obtain a membrane potential of –60 mV during drug testing.
Series resistance (in most cases ,20 MV) was not compensated.
Input resistance was assessed by injecting negative current pulses
(260 to 2150 pA, 500 ms) at 260 mV. After the whole cell patch
was formed, a depolarizing current pulse (,100–150 pA, duration
1 or 2 s) was applied before drug administration to induce
repetitive spiking during the pulse (control) and after application of
NE or carbachol (CCh) so that a long-lasting sustained repetitive
spiking, which outlasts the stimulation pulse (persistent firing), was
induced. This depolarization current pulse was sufficient to induce
persistent firing following drug administration and was kept
constant for every NE-responsive cell before and after drug testing.
The induced persistent firing could last for a significant period of
time (more than 10 min) after induction, but in almost all cases, it
was terminated by injecting a hyperpolarizing current 2 or 3
minutes after induction. The firing frequency is defined as the
average spiking frequency within 20 s after the depolarizing
current pulse. The plateau potential refers to the average
membrane potential during long lasting persistent firing or during
short (,20 s) sustained firing (ADP with superimposed action
potentials). The amplitude of plateau potentials reflects the
difference between the mean membrane potential (mV) measured
at baseline within one minute (before the pulse) and the mean
membrane potential measured during the steady-state phase of
persistent firing (excluding action potentials and afterhyperpolar-
izing potentials). In voltage clamp experiments for recording
excitatory postsynaptic currents, the membrane potential was held
at –70 mV (approximate reversal potential of inhibitory postsyn-
aptic currents) and series resistance was compensated (.70%). To
record the hyperpolarization-activated cation current (Ih), the
membrane voltage was held at –50 mV and followed by the
application of voltage steps (duration 2.5 s) ranging from –50 mV
to –110 mV, with increments of –10 mV, to neurons.
Optogenetics
Male tyrosine hydroxylase TH::IRES-Cre knock-in mice
(EM:00254; B6.129X1-Thtm1(cre)Te/Kieg; European Mouse
Mutant Archive) [30] were housed in a temperature- and
humidity-controlled (40–60%) room under a 12 h light/dark
cycle. Mice were given food and water ad libitum. Experimental
protocols were approved by McGill animal care committee and
meet the guidelines of the National Institutes of Health guide for
the Care and Use of Laboratory Animals. Cre-inducible recom-
binant adeno-associated viruses (AAV) [31,32,33,34] were used to
genetically target channelrhodopsin-2 (ChR2) expression to
noradrenergic neurons in the locus coeruleus as described
previously [33]. Double-floxed reverse EF-1a::ChR2(H134R)-
eYFP and EF-1a::eYFP cassettes were packaged in AAV vectors
and serotyped with AAV5 coat proteins to produce high-titer virus
preparations (261012 genome copies/ml; viral vector core facility
at the University of North Carolina). Eight- to 10-week-old male
TH::IRES-Cre mice were anesthetized using isoflurane. AAV
viruses were delivered stereotactically (from bregma: anterior-
posterior, –5.45 mm; lateral, 1.28 mm; and dorsal-ventral,
3.65 mm) as described previously [33]. One microliter of purified
double-floxed AAV:ChR2-eYFP or control AAV:eYFP virus was
injected bilaterally slightly laterally to the locus coeruleus area.
The location of the viral injection as well as ChR2(H134R)-eYFP
expression were verified by examining eYFP fluorescence in the
locus coeruleus in brainstem slices. All mice were singly housed
after surgery and recovered for at least 3 weeks before
electrophysiological experiments. Activation of ChR2 channels
was evoked by light pulses (10 ms pulse width) delivered at 3 Hz
for 5–10 min with a TTL-driven 473 nm blue laser (Laserglow
Technologies, Ontario, Canada). Tonic firing of 3 Hz in
noradrenergic neurons of the locus coeruleus is correlated with
active wakefulness in the rat and primate [35,36]. It appears that
high-frequency, non-physiological stimulation (.5 Hz) causes
Noradrenergic Persistent Activity in PFC
PLOS ONE | www.plosone.org 2 June 2013 | Volume 8 | Issue 6 | e66122
behavioral arrest and a decrease in cortical NE release as assessed
by microdialysis, suggesting depletion of NE in noradrenergic
terminals. Furthermore, 3 Hz of optical stimulation causes
effective sleep-to-wake transitioning and an increase in total
wakefulness in behavioral rats [33]. Therefore, we chose to deliver
3 Hz optical stimulation and simultaneously monitor excitatory
postsynaptic events in acute brain slices [33,36].
Drugs and Solutions
All drugs were purchased from Sigma (Oakville, Ontario,
Canada) except 6-methyl-2-(phenylethynyl)pyridine (MPEP), CGP
54626, 4-[1-Hydroxy-2-[(1-methylethyl) amino]ethyl]-1,2-benze-
nediol hydrochloride (isoproterenol) and ZD7288 which were
purchased from Tocris (Tocris Bioscience, Ellisville, MO),
propranolol from EMD biosciences and TTX from Alomone
Labs (Jerusalem, Israel). Carbachol, clonidine, (S)-3,5-dihydrox-
yphenylglycine hydrate (DHPG), isoproterenol, norepinephrine,
phenylephrine, prazosin, yohimbine, propranolol, TTX and
ZD7288 were dissolved in water whereas MPEP and CGP
54626 were dissolved in dimethyl sulfoxide (DMSO). All drugs
were freshly diluted from stock to the desired concentrations
before the experiments; the final concentration of DMSO did not
exceed 0.1%. In rats, the standard extracellular solution in current
clamp experiments contained (in mM): 125 NaCl, 2.5 KCl, 1.6
CaCl2, 2 MgCl2, 25 NaHCO3, 1.25 NaH2PO4, 3 pyruvic acid, 1.3
ascorbic acid, 10 glucose, 2 kynurenic acid and 0.1 picrotoxin.
Kynurenic acid and picrotoxin were used to block ionotropic
synaptic transmission mediated by NMDA, non-NMDA (AMPA
and kainate) and GABAA receptors, respectively. pH was
maintained at 7.4 by constant bubbling with carbogen (95% O2,
5% CO2). The intracellular solution in current clamp recordings
contained (in mM): 120 Kgluconate, 20 KCl, 2 MgCl2,0.2 EGTA,
10 HEPES, 7 di-tris phosphocreatine, 4 Na2-ATP and 0.3 Tris-
GTP. pH was adjusted to 7.3 with KOH. The extracellular
solution used in voltage clamp recordings of spontaneous
excitatory postsynaptic currents (sEPSCs) in rats was the same as
in current clamp recordings except that kynurenic acid was
omitted. BaCl2 (0.2 mM) was added to the extracellular solution in
voltage clamp experiments to record the hyperpolarization-
activated current (Ih). The intracellular solution used in voltage
clamp recordings is the same as the one used in current clamp
recordings. In optogenetic experiments in mice, the extracellular
solution for both voltage and current clamp recording contained
(in mM): 124 NaCl, 3 KCl, 1.6 CaCl2, 1.8 MgSO4, 26 NaHCO3,
1.25 NaH2PO4, 10 glucose, 0.1 picrotoxin pH 7.4. The intracel-
lular solution used is the same as in rats.
Data Analysis
Electrophysiological data were analyzed using Clampfit 9.2.1.8
(Axon Instruments) and Origin 6.0 (Microcal Software, North
Hampton, MA). Values are expressed as means 6 SEM. Synaptic
event (sEPSCs) data collected in 120 s episodes from voltage clamp
recordings before and after drug administration or light stimula-
tion were analyzed using the Mini Analysis Program (Synaptosoft
Inc NJ USA). The threshold for event detection was set at 10 pA.
Cumulative probability curves were compared using the Kolmo-
gorov-Smirnov two-sample test. Two-sample paired t-tests were
used to compare mean values obtained before and after drug
administration in the same neurons. Two-sample independent t-
tests were used for comparison between 2 independent groups.
One-way analysis of variance with Bonferroni correction was used
for comparison of multiple independent groups. Differences were
considered statistically significant when p,0.05.
Results
Norepinephrine Induces Persistent Firing in the PFC via
a1 Adrenoceptors
Some neurotransmitters and neuromodulators have been shown
to induce the generation of persistent firing in cortical pyramidal
neurons via Gq-coupled metabotropic receptors (e.g., muscarinic
M1, mGluR5) [14–19,22], but the exact role of norepinephrine
(NE) on the firing activity of the PFC is not clearly defined. We
observed that application of NE (10 mM) induced long-lasting
persistent neuronal firing following a depolarizing current pulse
injection in , 40% (57 out of 142) of the pyramidal neurons in
superficial layers (layer 2/3 and outer layer 5) of the PFC
(Figure 1A,B,D) in the presence of kynurenic acid and picrotoxin.
We never observed persistent activity before application of NE (0
out of 142). Interestingly, application of the muscarinic receptor
agonist carbachol (CCh) (10 mM) effectively induced persistent
firing in all neurons tested including those that did not respond to
NE (Figure 1C,D; n = 9), indicating that the cellular components
required for persistent activity are present in these neurons non-
responsive to NE. The NE response, characterized by a sustained
plateau potential, does not desensitize within 1 hr of perfusion
since persistent firing of approximately the same amplitude can be
further induced multiple times after termination by hyperpolar-
ization in the continuous presence of NE. Therefore, same cell
controls were used in all experiments (before and after drug pairs)
and, except when indicated otherwise, only neurons with induced
long-lasting persistent firing were used for drug testing and
analysis.
Application of the a1 adrenoceptor antagonist prazosin (2 mM)
completely blocked the response evoked by NE (Figure 1E,G;
n = 6). Furthermore, application of the selective a1 adrenoceptor
agonist phenylephrine (PE, 10 mM) also induced long-lasting
persistent firing in pyramidal neurons of the PFC (Figure 1F,G;
n = 10, 35% cells tested), confirming the involvement of a1
adrenoceptors in the NE-evoked persistent response.
a2 Adrenoceptor Activation Facilitates NE-induced
Persistent Firing
To test the contribution of a2 adrenoceptor activation in NE-
evoked persistent firing, we applied the a2 antagonist yohimbine
in the perfusion medium. Yohimbine (10 mM) partially inhibited
persistent firing evoked by NE (10 mM) (Figure 2A). Both the firing
frequency and the amplitude of the plateau potentials were
significantly decreased by yohimbine (frequency from 5.560.7 Hz
to 0.660.4 Hz, p,0.01, n = 6; amplitude from 11.760.9 mV to
3.561.5 mV, p,0.01, n = 6; Figure 2B). Interestingly, application
of the a2 agonist clonidine (10 mM) did not induce persistent firing
in pyramidal neurons (n = 10; not shown), suggesting that a2
adrenoceptor activation facilitates NE-induced persistent firing but
does not initiate it.
Application of the pan-b adrenoceptor blocker propranolol
(10 mM) did not have significant effects on the NE-induced
persistent firing (frequency 3.560.4 Hz to 2.860.5 Hz, p.0.05,
n = 9; amplitude from 14.061.4 mV to 8.860.8 mV, p.0.05,
n = 9; Figure 2C,D) and the b adrenoceptor agonist isoproterenol
(10 mM) did not induce persistent firing (n = 8, not shown). We
conclude that, despite the fact that a2 adrenoceptors contribute to
the modulation of persistent firing, neither a2 nor b adrenoceptors
play an important role in the initiation of persistent neuronal firing
in superficial pyramidal neurons of the PFC. Early reports
suggested that b adrenoceptor activation has no significant effect
on the working memory function of the PFC [37,38]. More recent
works described that activation of b1 adrenoceptors impairs
Noradrenergic Persistent Activity in PFC
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working memory [39], whereas activation of b2 adrenoceptors has
beneficial effects [40]. Because we did not observe any significant
effects of pan-b adrenoceptor blockade on noradrenergic persis-
tent firing, we did not investigate further the effects of different b
adrenoceptor subtypes.
a1 Adrenoceptor-Mediated Persistent Activity Depends
on mGluR5 Activation
As a neuromodulator, NE could have either direct postsynaptic
effects on pyramidal neurons by binding to postsynaptic
adrenoceptors on the dendrites and/or soma of the cells or
indirect effects through modulation of presynaptic neurotransmit-
ter release. We have previously reported that glutamatergic
persistent firing in the PFC is mediated by the metabotropic
receptor mGluR5 [22], but not ionotropic glutamate receptors.
Thus, we tested whether the NE effect was linked to mGluR-
evoked responses. Indeed, application of the selective mGluR5
antagonist MPEP (50 mM) suppressed NE-induced persistent
activity (Figure 3A). Both the firing frequency and the amplitude
of plateau potentials were reduced to a minimum, strongly
indicating an indirect effect of NE via release of glutamate and
activation of metabotropic glutamate receptors (frequency from
5.861.3 Hz to 0.960.5 Hz, p,0.01, n = 6; amplitude from
12.060.9 mV to 1.960.8 mV, p,0.01, n = 6; Figure 3A,C). In
agreement, the PE-induced and a1 adrenoceptor-mediated
persistent firing was also blocked by MPEP in pyramidal neurons
of the PFC (frequency from 7.260.4 Hz to 0.960.1 Hz, p,0.01,
Figure 1. NE induces persistent firing in pyramidal neurons of prefrontal cortex via activation of a1 adrenoceptors. (A) Left: Schematic
diagram of a coronal section of rat brain showing the recorded area (dots) in the prefrontal cortex including the rostral anterior cingulate cortex (ACC)
and prelimbic cortex (PrL). Adapted from Paxinos and Watson (1998). Right: Typical video image of a brain slice showing the recording site (with a
patch electrode) at layer 2/3 of the ACC subdivision of the prefrontal cortex. (B) Sample trace of NE (10 mM)-induced plateau potential and persistent
firing following a depolarizing current pulse in a pyramidal neuron. (C) In another group of neurons, NE failed to induce neuronal responses (non-
responsive cell, left panel). However, application of carbachol (CCh 10 mM) evoked persistent firing in the same neurons after NE washout (right
panel). (D) Quantification of frequency and amplitude of plateau potential of the NE (10 mM, n= 7) and CCh (10 mM, n= 9) effects. (E) NE-evoked
persistent firing (NE) is blocked by the selective a1 adrenoceptor antagonist prazosin (2 mM, NE+Praz, n = 6). (F) The selective a1 adrenoceptor agonist
phenylephrine (PE, 10 mM, n= 10) also induced NE-like persistent firing in pyramidal neurons of the prefrontal cortex. (G) Quantification of frequency
and amplitude of plateau potential of the prazosin and phenylephrine effects shown in E and F. Values are mean 6 SEM. *** p,0.001. The dashed
line in panel B, C, E and F represents the membrane potential at 260 mV. The short horizontal bar (2 s) underneath the recording trace represents
the current pulse stimulation. The description on dashed line and short horizontal bar also applies to Figures 2, 3, 5, 6, 7 and 8.
doi:10.1371/journal.pone.0066122.g001
Noradrenergic Persistent Activity in PFC
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n = 5; amplitude from 10.561.8 mV to 2.561.0 mV, p,0.01,
n = 5; Figure 3B,C). In contrast, within the same cells, the CCh-
induced persistent firing was not affected by MPEP (n = 4;
Figure 3D).
Noradrenergic Persistent Response is Linked to
Presynaptic Glutamate Release
To investigate a possible presynaptic site of action of NE on
axons or axon terminals in a1 adrenoceptor-mediated persistent
firing, we recorded glutamatergic excitatory synaptic events using
voltage clamp in superficial pyramidal neurons of the PFC in the
presence of the GABA blocker picrotoxin but with ionotropic
glutamatergic transmission intact. Bath application of NE (10–
100 mM) resulted in significant changes in the frequency and
amplitude of the spontaneous excitatory postsynaptic currents
(sEPSCs) (n = 12; shown at 10 min after NE, Figure 4A). NE
shifted the cumulative probability distribution curve of inter-event
intervals to the left while the curve of the amplitude was shifted to
the right, indicative of increases in frequency and amplitude,
respectively (Figure 4B,C). The average inter-event interval at
10 min was reduced from 2.460.4 s to 0.960.2 s (p,0.001,
n = 12; Figure 4D). The average amplitude of the sEPSCs was
increased from 30.662.9 pA to 35.962.9 pA (n = 12, p,0.001;
Figure 4E), indicating an involvement of postsynaptic adrenocep-
tors. Addition of the ionotropic glutamate receptor antagonist
kynurenic acid (1 mM) suppressed the NE effect (not shown,
n = 4), indicating that it is mediated by glutamate release and the
activation of ionotropic glutamate receptors. Furthermore, the NE
effect was also suppressed by application of the a1 adrenoceptor
antagonist prazosin (2 mM) (Figure 4A; n = 4). The inter-event
interval and amplitude of sEPSCs were almost fully reversed to
control levels after 10–15 min in the presence of prazosin
(Figure 4B–E). NE might increase the frequency of sEPSCs by
affecting the input resistance. We monitored the input resistance
during the experiments and noticed that some neurons showed an
increase in input resistance after NE application while others
showed slight decreases or no change. We nonetheless observed a
consistent increase in the measured frequency of sEPSCs. Thus, to
confirm a presynaptic effect of NE, we averaged the EPSCs with
large amplitudes (, 50–100 pA), which are supposed to be
generated near the soma, and the EPSCs with smaller amplitudes
(20–25 pA), which are supposed to come from remote dendritic
locations, from 3 neurons that displayed no significant changes in
input resistance. The falling phases of the EPSCs were fitted with a
single exponential function. We observed no significant difference
in the time to decay (peak to end) between the large and smaller
average EPSCs in all three neurons (p = 0.0887, p = 0.2688, and
p = 0.5928, respectively) indicating that, in these neurons, input
resistance is not the reason why smaller EPSCs are detected. Thus,
the detection of more sEPSCs is due to an increase in the
Figure 2. a2 adrenoceptors contribute to NE-induced persis-
tent firing. (A) NE-induced persistent firing was partially suppressed by
the selective a2 adrenoceptor antagonist yohimbine (Yohim, 10 mM;
n = 6). (C) NE-induced persistent firing was not affected by the
badrenoceptor antagonist propranolol (Prop, 10 mM; n= 9). (B) and
(D) Quantitative effects of yohimbine and propranolol on firing
frequency and amplitude of plateau potentials. Values are mean 6
SEM. ** p,0.01.
doi:10.1371/journal.pone.0066122.g002
Figure 3. NE-evoked and a1 adrenoceptor-mediated persistent activity depends on mGluR5 activation. (A) and (B) NE- and the selective
a1 adrenoceptor agonist phenylephrine (PE)-induced persistent firing were both blocked by the selective mGluR5 receptor antagonist MPEP (50 mM,
n= 6 and n= 5, respectively). (C) Quantitative results of the frequency and the amplitude of plateau potentials from neurons exemplified in A and B.
Values are mean 6 SEM. ** p,0.01. (D) MPEP failed to block CCh-induced persistent firing (n = 4).
doi:10.1371/journal.pone.0066122.g003
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frequency of sEPSCs. To further confirm a presynaptic effect of
NE and to check for a possible contribution of postsynaptic a1
receptor on persistent firing, we recorded miniature EPSCs
(mEPSCs) with TTX (1 mM) in the perfusion solution. We found
that the a1 adrenoceptor agonist phenylephrine (10 mM) increased
the frequency of mEPSCs consistently in 5 cells (control:
1.6560.4 Hz, phenylephrine: 2.1260.4 Hz, p = 0.0166, n = 5,
data not shown). There was a positive trend but no significant
effect of phenylephrine on the amplitude of mEPSCs (control:
13.6160.9 pA, phenylephrine: 15.8962.4 pA, p = 0.2240, n = 5,
data not shown). Interestingly we did not observe any significant
changes in both frequency and amplitude of mEPSCs in 2 cells
after phenylephrine application, confirming the existence of a
population of pyramidal neurons non-responsive to NE or
phenylephrine. Therefore, our findings support a TTX-insensitive
presynaptic site of action of NE through a1 adrenoceptors in a
subpopulation of superficial pyramidal neurons of the PFC.
To verify if activation of noradrenergic fibers originating from
the locus coeruleus could induce similar effects as exogenous NE
application in brain slices, we used an optogenetic approach. We
expressed ChR2-eYFP in noradrenergic neurons and their fibers
that project to the PFC by transducing the locus coeruleus of
(TH)::IRES-Cre knock-in mice with Cre-inducible adeno-associ-
ated virus as previously shown [33]. Three weeks post-injection, a
strong eYFP fluorescence was observed in the cell bodies of the
locus coeruleus neurons in brainstem slices (Figure 5A). A high
density of fluorescent axonal fibers and varicosities was also clearly
visible in prefrontal brain slices, indicating the expression of ChR2
(Figure 5A). Activation of the ChR2-expressing noradrenergic
fibers in acute brain slices of the PFC upon 3 Hz optical
stimulation (see ‘‘Materials and Methods’’) significantly enhanced
excitatory postsynaptic activity in superficial pyramidal neurons in
the absence of kynurenic acid in the perfusate (Figure 5B; n = 10).
The cumulative probability distribution curve of inter-event
intervals at 10 min was shifted to the left upon optical stimulation
with a mean inter-event interval reduced from 1.960.1 s to
0.960.1 s (p,0.001, n = 10, Figure 5C, 5E). This increase in
frequency of sEPSCs was suppressed by the selective a1 antagonist
prazosin (2,10 mM, Figure 5B–D; n = 4). The amplitude of
sEPSCs was also affected by optical stimulation as shown by the
right-shifted cumulative probability curve and the increase in the
mean amplitude of sEPSCs from 20.260.4 pA to 27.060.5 pA
(p,0.001, n = 10, Figure 5B,E,F). This increase in sEPSC
amplitude was significantly suppressed by prazosin (2,10 mM,
n = 4, Figure 5B,E,F), confirming a postsynaptic role for a1
adrenoceptors. Therefore, release of endogenous NE evoked by
optogenetic stimulation of prefrontal noradrenergic fibers could
effectively increase the frequency of glutamate release via the
activation of a1 adrenoceptors. However, no significant changes in
postsynaptic activities were observed in eYFP control mice (n = 2)
or eYFP-ChR2 mice without blue light stimulation (n = 5, not
shown). To further test if release of endogenous NE can contribute
to persistent activity, we recorded the activity of pyramidal
neurons in current clamp under optical stimulation. We observed
typical afterdepolarizations 5 min after optical stimulation (n = 5,
not shown). When the pyramidal neurons were primed with
threshold concentration (2 mM) of the group I metabotropic
receptor agonist DHPG, optically-evoked NE release triggered
long-lasting persistent firing (n = 3, Figure 5G).
NE-evoked Persistent Firing is Modulated by a2
Adrenoceptor-linked HCN Channels
Another question we pondered was why NE failed to evoke
persistent firing in a population of pyramidal neurons in superficial
layers of the PFC. It has been reported that presynaptic GABAA
receptors mediate presynaptic inhibition of glutamate release from
primary muscle afferents in the spinal cord, but have a facilitatory
effect on neurotransmitter release in the brainstem, cerebellum
and hippocampus [41,42,43]. It is possible that presynaptic
GABAA modulation of glutamate release affects persistent firing.
Therefore we performed further experiments to test if NE-induced
persistent firing is sensitive to blockade of fast GABAergic
transmission. We found that NE induces persistent firing in
pyramidal neurons in the absence of picrotoxin (n = 3, data not
shown), as observed in the presence of picrotoxin, suggesting that
GABAA modulation of glutamate release does not play a major
role. The failure of NE to induce persistent firing in a population
of cells could also result from tonic GABAergic inhibition
mediated by GABAB receptors. To test this possibility, we added
the selective GABAB receptor antagonist CGP 54626 in the
perfusate. Application of CGP 54626 (10 mM) together with NE
did not unmask any excitatory effect in the NE non-responsive
cells (n = 4; not shown), excluding a major role for metabotropic
GABAergic modulation in the expression of NE-evoked persistent
responses in pyramidal neurons.
Previous reports have demonstrated that HCN channels are
expressed on dendritic spines of pyramidal neurons in the PFC
Figure 4. NE stimulates glutamate release in the prefrontal
cortex. (A) Sample traces showing that NE (10–100 mM; n= 12)
increases the frequency and amplitude of spontaneously occurring
EPSCs (sEPSCs) in pyramidal neurons (Vh=270 mV). Traces on the left
and right are on different time scales. Prazosin (2 mM, n= 4) blocked this
facilitatory effect. (B) and (C) Cumulative probability distribution curves
for inter-event interval (reciprocal of frequency) and for amplitude of
sEPSCs showing the NE-induced increase in frequency and amplitude of
sEPSCs. Prazosin significantly suppressed the NE effect. (D) and (E)
Quantitative effects of NE and NE+prazosin on inter-event intervals and
amplitude of sEPSCs. Values are mean 6 SEM. ** p,0.01; *** p,0.001.
doi:10.1371/journal.pone.0066122.g004
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Figure 5. Optogenetically-evoked NE release enhances persistent firing. (A) Micrographs of AAV-infected and fluorescent eYFP-positive,
ChR2-expressing noradrenergic neurons in the locus coeruleus (left) and their axonal fibers with varicosities in the medial prefrontal cortex of TH::Cre
transgenic mice (right). (B) Representative traces showing that blue light (473 nm, 3 Hz, 10 ms, .10 mW/mm2, n = 10) increased both the frequency
and amplitude of sEPSCs in pyramidal neurons (Vh=270 mV). Traces on the left and right are on different time scales. Prazosin (2,10 mM, n= 4)
blocked this excitatory effect. (C) and (E) Cumulative probability distribution curves for inter-event interval and amplitude of sEPSCs showing the
increase in the frequency and amplitude of sEPSCs. Prazosin significantly suppressed the ChR2-induced effects. (D) and (F), Quantitative effects of
Noradrenergic Persistent Activity in PFC
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and that blockade of HCN channels via a2 adrenoceptor
activation enhances recurrent network interactions in ferret PFC
slices and increases delay-related firing for preferred directions in
behavioral monkeys [44]. To test if the intrinsic persistent firing of
rat medial PFC pyramidal neurons is modulated by HCN channel
activity, we examined the effect of the selective HCN channel
blocker ZD7288. Bath application of ZD7288 (30 mM) alone did
not induce persistent firing (n = 10, not shown). However,
treatment with ZD7288 enhanced the persistent response of a
population of pyramidal cells to NE (10 mM): both the average
firing frequency and the amplitude of plateau potentials of NE-
evoked responses were significantly increased (frequency from
0.660.3 Hz to 3.860.6 Hz, p,0.001, n = 12; amplitude from
2.560.6 mV to 11.261.1 mV, p,0.001, n = 12, Figure 6A,B).
Interestingly, besides the enhancement of persistent firing by
ZD7288 in 6 of the 12 cells tested, the other 6 non-responsive cells
showed strong persistent firing in response to NE following
addition of ZD7288 (Figure 6A). The fact that blockade of HCN
channels converted non-responsive neurons into neurons with
persistent firing indicates that differential adrenoceptor expression
and/or distinct intrinsic neuronal properties (e.g., HCN expression
levels) likely account for the different responses to NE [45].
Recently, Huang and coll. [46] have shown that, with ZD7288
applied intracellularly through the patch pipette, bath application
of ZD7288 increases the frequency, but not the amplitude, of
mEPSCs compared to control (ZD7288 in pipette only). This
indicates that presynaptic HCN channels regulate glutamate
release and that the diffusion of ZD7288 from postsynaptic to
presynaptic sites of action is limited within the recording time
period (15–20 min). Therefore, we added the HCN channel
blocker ZD7288 (30 mM) in the recording pipette. Intracellularly
applied ZD7288 enhanced neuronal responses to a threshold dose
of NE (2.5 mM, n = 5, compared to control, a separate group of
neurons, n = 5; Figure 6C,D) to a similar extent as bath applied
ZD7288 (Figure 6A,B), indicating that the NE-evoked persistent
firing is mainly mediated by blockade of postsynaptic HCN
channels. Furthermore, we applied hyperpolarizing and depolar-
izing current pulses to superficial pyramidal neurons through the
recording electrode and measured membrane input resistance as
well as neuronal excitability (Figure 6E,F). Application of ZD7288
(30 mM) completely eliminated the current pulse-evoked depolar-
izing membrane potential sag typically caused by HCN channel-
mediated inward Ih currents (n = 7, Figure 6E right panel).
Moreover, ZD7288 increased the membrane input resistance
(from 136.7615.2 MV to 197.7616.5 MV, p,0.001, n = 7,
Figure 6E and Figure 6F left panel), as well as the cell
responsiveness (number of action potentials) to depolarizing
current pulses (from 1.860.4 spikes/500 ms to 3.260.7 spikes/
500 ms, p,0.01, n = 7, Figure 6E left panel, 6F right panel),
indicating that blockade of postsynaptic HCN channels mediates
the enhancement of cell excitability and NE-evoked persistent
firing.
It has been reported that activation of a2 adrenoceptors inhibits
HCN channels [47,48]. As shown above, neither the a2
adrenoceptor agonist clonidine nor the selective HCN channel
blocker ZD7288 induces persistent firing in pyramidal neurons,
indicating that inhibition of HCN channels alone by NE (via a2
adrenoceptors) is not sufficient; it requires other components (e.g.,
glutamate released via a1 adrenoceptors) to induce persistent
firing. To test the modulatory role of HCN channels on
metabotropic persistent firing, we used the group I mGluR agonist
DHPG to directly mimic a1 adrenoceptor-mediated release of
glutamate. A threshold dose of DHPG (2 mM) induced slight
responses in prefrontal pyramidal neurons in the absence of
ZD7288; however, when we applied ZD7288 in the bath
(Figure 7A) or in the pipette (Figure 7B, in a separate group of
neurons from control), DHPG (2 mM) induced strong persistent
firing (frequency from 0.160.3 Hz to 7.360.7 Hz, p,0.01,
amplitude from 3.560.9 mV to 22.563.5 mV, p,0.05, n = 3 in
blue light and the antagonistic effect of prazosin on inter-event intervals and amplitude of the sEPSCs. Values are mean 6 SEM. ** p,0.01; ***
p,0.001. (G) Enhancement of DHPG-evoked response by optically-induced NE release and recovery.
doi:10.1371/journal.pone.0066122.g005
Figure 6. Noradrenergic responses are modulated by postsyn-
aptic HCN channel activity. (A) A typical trace from a pyramidal
neuron showing minimal response to bath application of NE (10 mM)
(left panel). Co-application of NE and the selective HCN channel blocker
ZD7288 (30 mM) in the bath solution in the same neuron significantly
enhanced the NE-induced response (n = 12, right panel). (B) Quantita-
tive effects of bath ZD7288 on firing frequency and amplitude of
plateau potentials of NE-evoked response. (C) A threshold dose of NE
(2.5 mM) induced afterdepolarization and short sustained firing (Left,
without ZD7288, n = 5). In another group of neurons with ZD7288 in the
recording pipette, NE induced strong persistent firing (Right, ZD7288 in
pipette, n = 5). (D) Quantitative effects of intracellular ZD7288 on the
firing frequency and amplitude of plateau potentials. (E) Sample traces
of current step-evoked membrane potential responses before (control)
and after ZD7288 application showing an increase in voltage responses
(response to 40 pA current step shown in red) (left panel, n = 7). Current
step stimulation from -140 pA to a maximum of 40 pA with 20 pA
increments. Right: Membrane potential response to a -140 pA current
step in control and in the presence of ZD7288. Note that the
depolarizing membrane potential sag, a characteristic feature of HCN
channel activation, was completely suppressed by ZD7288. (F) Input
resistance (calculated at 2200 pA) and number of spikes during the
40 pA current pulse (500 ms) before and after ZD7288 administration
(n = 7). Values are mean 6 SEM. ** p,0.01; *** p,0.001.
doi:10.1371/journal.pone.0066122.g006
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bath; and frequency from 0.660.3 Hz to 4.660.7 Hz, p,0.0005,
amplitude from 2.260.7 mV to 14.160.6 mV, p,0.0001, n = 5
in pipette, respectively), indicating that blockade of postsynaptic
HCN channels indeed enhances glutamatergic persistent firing in
the pyramidal neurons of the PFC.
The involvement of a2 adrenoceptor activation and HCN
channel blockade in the enhancement of cell excitability and NE-
induced persistent firing was further confirmed when we tested the
effect of the a2 adrenoceptor agonist clonidine on HCN channel
activity. We found that clonidine (10,20 mM) suppressed
hyperpolarization-evoked inward currents (Figure 7C–F, n = 7),
indicating that the activation of a2 adrenoceptors inhibits Ih.
Next, we used DHPG to mimic the a1 adrenoceptor-mediated
release of glutamate and tested the effect of a2 adrenoceptor
activation on metabotropic persistent firing. We found that the
afterdepolarization or short persistent firing evoked by a threshold
concentration of DHPG (2 mM) was converted by clonidine
(10 mM) to bona fide long-lasting persistent firing (n = 5, frequency
from 4.460.8 Hz to 6.861.1 Hz, p,0.01; amplitude from
12.660.7 mV to 16.260.9 mV, p,0.05; Figure 7G,H), indicating
that both a1 and a2 adrenoceptors are required to synergistically
mediate a strong noradrenergic persistent activity.
Figure 7. Glutamatergic persistent firing is enhanced by a2 adrenoceptor-mediated HCN channel inhibition. (A) and (B) Quantitative
effects of bath and in-pipette ZD7288 (30 mM) on responses of PFC pyramidal neurons to a threshold dose of DHPG (2 mM). (C), (D) and (E) Sample
traces showing clonidine-sensitive Ih currents (E) at different membrane voltages obtained by subtracting current responses to voltage steps after
bath application of clonidine (10 mM) (D) from pre-drug control (C). Hyperpolarization-evoked Ih currents were inhibited by clonidine. Ih current
responses were evoked by hyperpolarization voltage steps (duration 2.5 s) from 250 mV to –110 mV in 10 mV increments. (F) Steady state I-V
relationship of the Ih current in the absence (Control) and presence of clonidine. Instantaneous currents were subtracted. Ih was inhibited by
clonidine (10–20 mM) at different membrane voltages. (G) Representative traces showing that the response of prefrontal pyramidal neurons to
threshold doses of DHPG (2 mM, left panels) are enhanced by co-application of the a2 adrenoceptor agonist clonidine (10 mM, n= 5, right panel). (H)
Quantitative effects of clonidine on DHPG-induced firing frequency and amplitude of plateau potentials. Values in A, B, F and H are mean 6 SEM. *
p,0.05; ** p,0.01; *** p,0.001.
doi:10.1371/journal.pone.0066122.g007
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NE Enhances Cholinergic Persistent Firing via a2
Adrenoceptors and HCN Channels
Activation of muscarinic cholinergic receptors induces persistent
firing in pyramidal neurons of the PFC [22]. Furthermore, this
report demonstrated that both the muscarinic cholinergic and the
mGluR5 receptors converge on the same downstream intracellular
signaling pathway that drives persistent firing [22]. Knowing that
presynaptic a1 adrenoceptor-mediated glutamate release leads to
mGluR5 responses that are additive to muscarinic responses, we
wanted to assess the contribution of a2 adrenoceptor-linked HCN
channels in the noradrenergic modulation of cholinergic persistent
firing. To this end, we first studied the response of pyramidal
neurons to co-application of CCh and NE. We found that a low
concentration of NE (2.5 mM) significantly enhanced the excit-
atory responses of pyramidal neurons to threshold doses of CCh
(0.5–2.5 mM) (n = 5, frequency from 0.960.2 Hz to 3.560.5 Hz,
p,0.01; amplitude from 3.560.6 mV to 12.661.5 mV, p,0.01;
Figure 8A,B).
To further pinpoint the mechanism of the noradrenergic
modulation of cholinergic persistent firing, we tested the effects
of a2 adrenoceptor activation or blockade of HCN channels on
muscarinic responses. Threshold doses of CCh alone only induced
short afterdepolarizations or short low frequency sustained
neuronal firing in response to depolarizing current pulse injections.
However, in the presence of clonidine (10 mM) or ZD7288
(30 mM), threshold doses of CCh evoked strong long-lasting
persistent firing (Figure 8C–F). The average firing frequency and
amplitude of plateau potentials were both dramatically increased
in both conditions (clonidine: n = 6, frequency from 0.260.1 Hz
to 3.660.7 Hz, p,0.01; amplitude from 3.860.3 mV to
13.961.0 mV, p,0.001. ZD7288: n = 6, frequency from
0.360.1 Hz to 3.360.4 Hz, p,0.01; amplitude from
3.260.7 mV to 11.661.1 mV, p,0.01) (Figure 8D and F,
respectively). We conclude that the facilitatory effects of NE on
the muscarinic persistent response can be mediated by the
activation of a2 adrenoceptors and subsequent inhibition of
HCN channels in pyramidal neurons of the PFC.
Discussion
NE-evoked Persistent Firing Depends on a1
Adrenoceptors
Immunohistochemical studies have documented dense norad-
renergic fibers in the superficial layers of the neocortex [49,50].
Autoradiographic ligand binding studies demonstrated that a1
adrenoceptor binding sites are abundant in superficial layers of the
neocortex [51,52]. Recent studies combining immunocytochem-
istry and electron microscopy have shown the expression of a1
adrenoceptors in axons or presynaptic terminals of excitatory
neurons in the visual cortex [53], striatum and midbrain [54]. In
the present study, we report that the NE-evoked persistent
responses are completely blocked by the a1 antagonist prazosin
while the selective a1 agonist phenylephrine induces persistent
firing. Furthermore, the excitatory postsynaptic activity evoked by
bath or endogenous NE was nearly completely abolished by
prazosin, indicating the involvement of a1 adrenoceptors. In situ
hybridization histochemistry has revealed significant a1 mRNA
signals in thalamic nuclei and layers 2–5 neurons of the cerebral
cortex [55,56]. These a1 adrenoceptor-expressing neurons in the
thalamus and the cerebral cortex projecting to layer 2/3 of the
PFC are the probable sites of action of NE.
Figure 8. NE enhances cholinergic persistent neuronal firing
via a2 adrenoceptor and HCN channel modulation. (A), (C) and
(E) Threshold doses of CCh (0.5–2.5 mM) induce afterdepolarization
potentials or short sustained firing (left panel). NE, clonidine and
ZD7288 significantly enhanced the muscarinic response in pyramidal
neurons of the prefrontal cortex (right panel). (B), (D) and (F)
Quantitative effects of NE (n = 5), clonidine (n = 6) or ZD7288 (n = 6)
on CCh-induced firing frequency and amplitude of plateau potentials.
Values are mean 6 SEM. ** p,0.01. *** p,0.001.
doi:10.1371/journal.pone.0066122.g008
Figure 9. Molecular components involved in NE-induced
persistent firing in superficial pyramidal neurons of prefrontal
cortex. NE released from noradrenergic varicosities in the prefrontal
cortex binds to pre- and postsynaptic a1 adrenoceptors. Activation of
presynaptic a1 adrenoceptors facilitates glutamate release. Glutamate
activates postsynaptic mGluR5 and induces persistent neuronal firing.
Postsynaptic a2 adrenoceptors and HCN channels colocalize on
dendritic spines [44]. Activation of postsynaptic a2 adrenoceptors by
NE inhibits cAMP signaling and blocks HCN channels thereby increasing
membrane input resistance, cell excitability and the efficacy of synaptic
transmission. Cholinergic inputs induce persistent neuronal firing driven
by M1 muscarinic receptors via TRPC channel-dependent mechanisms
[24]. a2 adrenoceptor-mediated inhibition of HCN channels underlies
NE-mediated modulation of cholinergic persistent firing. Ach: acetyl-
choline; Glu: glutamate.
doi:10.1371/journal.pone.0066122.g009
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Noradrenergic Persistent Firing Requires mGluR5
Activation
We provide several pieces of evidence to support the notion that
the NE effect is indirectly mediated by presynaptic glutamate
release: first, both NE- and the selective a1 agonist phenylephrine-
evoked persistent firing were blocked by the mGluR5 blocker
MPEP; second, both bath-applied NE and endogenous NE from
the locus coeruleus increased the frequency of the sEPSCs and
third, bath-applied phenylephrine increases the frequency of
mEPSCs (in the presence of TTX). The fact that persistent firing
induced by a high concentration of NE (100 mM, n = 3) is still
blocked by the mGluR5 blocker MPEP indicates that mGluR
activation is necessary for NE-induced persistent firing. Our results
are in agreement with previous reports showing that NE can
increase the frequency of EPSCs through a1 adrenoceptor
activation in the hypothalamus [57,58] and layer 5 of the PFC
[59]. The prazosin-sensitive increase in the amplitude of sEPSCs
induced by both bath NE and endogenous NE release indicates
the expression of functional postsynaptic a1 adrenoceptors. This
suggests that the persistent response to NE could involve additive
postsynaptic effects of a1 adrenoceptor and mGluR5 activation.
This increase in amplitude of sEPSCs may also be the result of
highly synchronized multivesicular glutamate release. Such
synchronized multivesicular release has also been observed with
other neuromodulators in various brain areas [60,61]. The NE-
induced glutamate release (recorded as kynurenic acid-sensitive
EPSCs) could originate from synaptic terminals of adjacent
neurons and/or from axon terminals of remote neurons making
synaptic contacts with adjacent neurons.
Activation of Group I mGluRs induces afterdepolarizations and
persistent firing in the PFC [19,22]. Interestingly, in the present
study, the endogenous NE released by activation of light-gated
ChR2 expressed in fibers from the locus coeruleus induced typical
afterdepolarizations and persistent firing in the presence of a
threshold amount of the group I mGluR agonist DHPG,
indicating that endogenous release of NE can effectively modulate
mGluR5 signalling via an enhancement of glutamate release. It is
conceivable that in awake conditions, moderate NE levels induce
persistent firing in the PFC through presynaptic release of
glutamate, thereby promoting working memory performances.
Accordingly, it has been shown that the decrease in group I
mGluR function in the PFC causes impaired working memory
performance [62,63]. Furthermore, blockade of mGluR5 by
systemic MPEP impaired working memory in the rat [64,65].
Therefore, normal working memory requires the coordinated
release of both NE and glutamate as well as the intact functional
mGluRs in the PFC [66].
HCN Channels Modulate Noradrenergic and Cholinergic
Persistent Firing
It has been reported that activation of a2 adrenoceptors inhibits
HCN channels and enhances delay-related prefrontal firing and
working memory performance [44,48,67]. In agreement, we
observed at the cellular level that NE-evoked responses are
enhanced by blockade of postsynaptic HCN channels. The
blockade of postsynaptic HCN channels increases input resistance
of superficial pyramidal neurons in the PFC and enhances NE-
evoked neuronal activity. Furthermore, we observed that a2
adrenoceptor activation modulates HCN channel-mediated Ih
current and the mGluR5-mediated afterdepolarization is en-
hanced by simultaneous blockade of HCN channels and co-
activation of a2 adrenoceptors. Therefore, the NE-mediated
persistent firing in the PFC requires both a1 and a2 adrenoceptor
activation. NE not only initiates persistent firing via a1
adrenoceptors and presynaptic glutamate release but also
enhances it via a2 adrenoceptors, HCN channel modulation and
increased postsynaptic excitability.
Activation of postsynaptic muscarinic receptors also induces
persistent firing in pyramidal neurons of the PFC and other
cortical areas [20,22,24,68]. Activation of muscarinic receptors
enhances synaptic summation in layer 5 pyramidal neurons of the
PFC via blockade of several K+ conductances [69,70]. Dendritic
excitability of prefrontal pyramidal neurons has been shown to
depend on the interaction between HCN, Kir2 and Kleak channels
[69]. Our results indicate that both activation of a2 adrenoceptors
and modulation of HCN channels can enhance CCh-evoked
muscarinic responses suggesting that HCN channels are involved
in the adrenergic modulation of cholinergic persistent firing. This
HCN channel-dependent mechanism reveals a novel mode of
crosstalk between cholinergic and adrenergic inputs in the PFC.
Role of a1 Adrenoceptors in Working Memory
In the present study, we observed an indirect excitatory effect of
NE on pyramidal neurons in the PFC through presynaptic a1
adrenoceptor-mediated glutamate release and postsynaptic
mGluR5 activation. It has been proposed that high levels of NE
inhibits prefrontal neuronal discharges and impairs working
memory performance via postsynaptic a1 adrenoceptor-mediated
PKC activation [29]. It is important to note that the a1
adrenoceptor-mediated excitatory effect in our study is mainly of
presynaptic origin, whereas the inhibitory effect of a1 adrenocep-
tors in the above-mentioned work has been shown to be
postsynaptic. There is increasing evidence for direct postsynaptic
excitatory effects of several Gq-coupled metabotropic receptors
(e.g., muscarinic, mGluR5, orexin receptor 1, 5-HT2A) on
pyramidal neuron firing in various cortical regions [20,22,71,72].
The Gq-coupled and PLC-linked persistent firing has been shown
to require a non-selective cation current mediated by TRPC4
and/or TRPC5-containing channels [24]. Why postsynaptic Gq-
coupled a1 adrenoceptors are not able to trigger plateau potentials
and persistent firing will remain to be determined. Their surface
density, subcellular localization or coupling to intracellular
effectors could be critical parameters for their contribution to
persistent responses. Why the activation of metabotropic receptors
and associated Gq-PLC signaling can lead to an enhancement of
neuronal firing whereas the activation of downstream PKC causes
inhibition [29] is also unknown. It is possible that a strong and
sustained activation of PKC desensitizes a1 adrenoceptors [73] or
suppresses the mechanism required for the induction of persistent
firing. Indeed, it has been reported that TRPC4/5 channels
mediating metabotropic persistent firing are desensitized by
diacylglycerol-induced activation of PKC [74,75]. Following co-
application of the muscarinic agonist CCh with 1-oleoyl-2-acetyl-
sn-glycerol, an analogue of the PKC activator diacylglycerol,
pyramidal cells gradually displayed an inhibition of the CCh-
evoked persistent firing in acute entorhinal brain slices (unpub-
lished data), indicating an inhibitory effect of PKC activation
through TRPC4/5 channel desensitization. Therefore, in certain
conditions, a direct inhibitory effect of postsynaptic a1 adreno-
ceptor activation could be caused by PKC-mediated desensitiza-
tion of adrenoceptors and/or TRPC channels.
At the behavioural level, activation of a1 adrenoceptors is
associated with attentional set shifting and cognitive flexibility in
rats [76,77], as well as with perseverative patterns of responses in
stressed rats performing working memory tasks [28,78]. There is a
large increase in monoamine [79,80] and glutamate [81] release in
the PFC during stress. Moreover, overstimulation of a1 adreno-
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ceptors was observed in patients with hypermnesia and anxiety-
related syndromes such as PTSD [82–84]. Blockade of a1
adrenoceptors with prazosin has been used as a therapeutic
strategy to reduce the reoccurrence of traumatic nightmares in
patients with PTSD and to decrease relapse in patients with
alcohol dependence [85–87]. Therefore, besides being involved in
normal cognition, a1 adrenoceptor-mediated persistent firing is
also likely associated with overexcitability and inappropriate
activity in stress-induced pathological conditions, underlying the
therapeutic effects of prazosin in the PFC.
In conclusion, we observed that NE, by acting on pre- and
postsynaptic a1 adrenoceptors as well as postsynaptic a2
adrenoceptors (Figure 9), evokes robust persistent activity in
pyramidal neurons in superficial layers of the PFC where the
microcircuits responsible for working memory reside [3,10]. This
synergistic combination of intrinsic and network properties
provides a novel mechanism for noradrenergic induction and
enhancement of persistent firing in prefrontal pyramidal neurons
in normal or hyperexcitable states.
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